TP53 Mutations in Stage I Gallbladder Carcinoma with Special Attention to Growth Patterns

Author： Hanada K. Itoh M. Fujii K. Tsuchida A. Hirata M. Iwao T. Eguchi N. Sasaki T. Matsubara K. Kajiyama G.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.7, 1997-06, pp. : 1136-1140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth Factor Requirement, Oncogene Expression and TP53 Mutations of a Tumorigenic and a Non-tumorigenic Subline of the Human Breast Carcinoma Cell Line, HMT-3909

By Madsen M.W. Moyret C. Theillet C. Briand P.

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 362-367

Elsevier

Access to resources Recommend Favorite

TP53 Mutation in Ovarian Carcinoma

By Murphy M. McManus D.T. Toner P.G. Russell S.E.H.

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1281-1283

Elsevier

Access to resources Recommend Favorite

TP53 oncomorphic mutations predict resistance to platinum and taxanebased standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 607-618

Spandidos Publications

Access to resources Recommend Favorite

Detection of TP53 Gene Mutations in Human Sarcomas

By Castresana J.S. Rubio M.-P. Gomez L. Kreicbergs A. Zetterberg A. Barrios C.

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 735-738

Elsevier

Access to resources Recommend Favorite

Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma - influence of tumour site, stage, adjuvant chemotherapy and type of mutation

By Soong R. Powell B. Elsaleh H. Gnanasampanthan G. Smith D.R. Goh H.S. Joseph D. Iacopetta B.

European Journal of Cancer, Vol. 36, Iss. 16, 2000-10 ,pp. : 2053-2060

Elsevier

Access to resources Recommend Favorite